WELL Health Technologies Corp.
TSX:WELL.TO
4.29 (CAD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 776.054 | 569.136 | 302.324 | 50.24 | 32.811 | 5.897 | 0.415 | 0.285 | 0.411 | 0 | 0 | 0 |
| Cost of Revenue
| 464.555 | 265.845 | 148.629 | 29.025 | 21.821 | 4.167 | 0.287 | 0.236 | 0.026 | 0 | 0 | 0 |
| Gross Profit
| 311.499 | 303.291 | 153.695 | 21.215 | 10.989 | 1.73 | 0.128 | 0.048 | 0.384 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.401 | 0.533 | 0.508 | 0.422 | 0.335 | 0.293 | 0.309 | 0.169 | 0.936 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 3.461 | 3.151 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 212.689 | 176.411 | 107.747 | 25.758 | 14.92 | 3.784 | 0.978 | 0.532 | 0.042 | 0.04 | 0.122 | 0.055 |
| Selling & Marketing Expenses
| 64.289 | 47.695 | 15.775 | 1.593 | 0.035 | 0 | 0.057 | 0.089 | 0.002 | 0 | 0 | 0 |
| SG&A
| 270.39 | 224.106 | 123.522 | 27.352 | 14.92 | 3.784 | 1.034 | 0.622 | 0.042 | 0.04 | 0.122 | 0.055 |
| Other Expenses
| -5.16 | 55.203 | 38.216 | 4.27 | 2.155 | 0.036 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 270.39 | 279.309 | 161.738 | 31.622 | 17.075 | 3.82 | 1.034 | 0.622 | 0.042 | 0.04 | 0.122 | 0.055 |
| Operating Income
| 41.109 | 23.311 | -6.209 | -9.896 | -5.607 | -2.015 | -0.906 | -0.573 | -0.042 | -0.04 | -0.123 | -0.055 |
| Operating Income Ratio
| 0.053 | 0.041 | -0.021 | -0.197 | -0.171 | -0.342 | -2.184 | -2.015 | -0.102 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -21.234 | -5.39 | -18.556 | 2.91 | -2.151 | -0.019 | -4.636 | -0.012 | -0.106 | 0.004 | 0.005 | -0.001 |
| Income Before Tax
| 19.875 | 17.921 | -24.765 | -6.986 | -7.759 | -2.034 | -5.566 | -0.585 | -0.146 | -0.036 | -0.119 | -0.054 |
| Income Before Tax Ratio
| 0.026 | 0.031 | -0.082 | -0.139 | -0.236 | -0.345 | -13.418 | -2.057 | -0.355 | 0 | 0 | 0 |
| Income Tax Expense
| 2.86 | -1.15 | 5.921 | -4.362 | 0.035 | 0.009 | 4.636 | -0.001 | 0.103 | -0.005 | -0.006 | -0.002 |
| Net Income
| 0.082 | 19.071 | -30.686 | -2.624 | -7.794 | -2.044 | -5.566 | -0.585 | -0.146 | -0.036 | -0.119 | -0.054 |
| Net Income Ratio
| 0 | 0.034 | -0.102 | -0.052 | -0.238 | -0.347 | -13.418 | -2.057 | -0.355 | 0 | 0 | 0 |
| EPS
| 0 | 0.086 | -0.16 | -0.02 | -0.08 | -0.031 | -0.24 | -0.059 | -0.022 | -0.005 | -0.023 | -0.012 |
| EPS Diluted
| 0 | 0.086 | -0.16 | -0.02 | -0.08 | -0.031 | -0.24 | -0.059 | -0.022 | -0.005 | -0.023 | -0.012 |
| EBITDA
| 101.877 | 77.308 | 32.007 | -5.626 | -3.452 | -1.979 | -0.906 | -0.573 | -0.039 | -0.035 | -0.117 | -0.055 |
| EBITDA Ratio
| 0.131 | 0.136 | 0.106 | -0.112 | -0.105 | -0.336 | -2.184 | -2.013 | -0.095 | 0 | 0 | 0 |